LONGEVITY FIRMS PUSH MONTANA TO BECOME HUB FOR BIOHACKING, EXPERIMENTAL TREATMENTS

Summary from the TLDR newsletter

Montana passed a law in 2023 that allows any patient to access experimental treatments, not just those with terminal illnesses. In May, the state's governor signed a bill to create a framework for licensed treatment centers to offer access to therapies that have passed a Phase 1 safety trial. Patients are unlikely to receive their first therapies under the law before 2026, but roughly 20 businesses, ranging from small biotech companies to medical clinic operators, have already reached out to express interest in operating in Montana under the new law. Healthcare providers and drug makers will be largely protected from legal liability if patients are harmed unless they are negligent or fail to get proper consent from patients.